Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Incidence of adverse events (AEs) related to IDP-73152 mesylate
| Placebo (N=12) | 40 mg (N=6) | 80 mg (N=6) | 160 mg (N=8) | 320 mg (N=8) | 640 mga (N=8) | 1280 mg (N=8) | |
|---|---|---|---|---|---|---|---|
| Abdominal discomfort | 1 | ||||||
| Abdominal pain | 1 | ||||||
| Diarrhoea | 1 | ||||||
| Dysgeusia | 1 | ||||||
| Epigastric discomfort | 1 | ||||||
| Lip ulceration | 1 | ||||||
| Mouth ulceration | 1 | ||||||
| Nausea | 1 | 1 | 4 | ||||
| Headache | 1 | 1 | |||||
| Somnolence | 1 |
Note: aIn the 640 mg of IDP-73152 mesylate, drug-related adverse event occurred in fasted state.
